Rodrigo T. Cartaxo

Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

Sriram Venneti, Abed Rahman Kawakibi, Sunjong Ji et al. · Cancer Discovery · 2023 · 154 citations · Full text

Medicine, Cancer Biology, Oncology +14

Serial H3K27M cell-free tumor DNA (cf-tDNA) tracking predicts ONC201 treatment response and progression in diffuse midline glioma

Evan Cantor, Kyle Wierzbicki, Rohinton S. Tarapore et al. · Neuro-Oncology · 2022 · 122 citations · Full text

Medicine, Oncology, Pharmacology +13

Everolimus improves the efficacy of dasatinib in PDGFRα-driven glioma

Zachary Miklja, Viveka Nand Yadav, Rodrigo T. Cartaxo et al. · Journal of Clinical Investigation · 2020 · 75 citations · Full text

Medicine, Oncology, Pharmacology +17

GABAergic neuronal lineage development determines clinically actionable targets in diffuse hemispheric glioma, H3G34-mutant

Ilon Liu, Gustavo Alencastro Veiga Cruzeiro, Lynn Bjerke et al. · Cancer Cell · 2024 · 49 citations · Full text

Life Sciences, Neuroscience, Oncology +17

Clinical, genomic, and epigenomic analyses of H3K27M-mutant diffuse midline glioma long-term survivors reveal a distinct group of tumors with MAPK pathway alterations

Holly Roberts, Sunjong Ji, Alberto Pïcca et al. · Acta Neuropathologica · 2023 · 34 citations · Full text

Medicine, Genetics, Oncology +16